A novel KRAS exon 2 drop-off digital PCR assay for mutation detection in cell-free DNA of cancer patients
{{output}}
Background: KRAS exon 2 mutations are highly prevalent in human malignancies, making them attractive targets for detection and monitoring in cell-free DNA (cfDNA) of cancer patients. Drop-off assays designed for digital polymeras... ...
